Only short depositions between 2.5 and 240 min were performed.
Dynamic [11C]CB184 PET scans (90 min) were performed in five healthy male subjects.
Delayed static scans (10 min) were performed at 3 h post injection in all rats (n = 10).
Ultrasonic treatments of TiO2 Ws for about 30 to 50 min were performed in the following experiments.
In this study, interviews of 30 50 min were performed for each group, spanning a period of 2 months (February to March of 2015).
Following a low-dose CT scan for attenuation correction, dynamic PET scans lasting 90 min were performed on a Siemens HiRez 6 PET-CT scanner (Siemens, Munich, Germany) after intravenous administration of [11C]lapatinib.
This phase of the research lasted approximately four-and-a-half months (from late April to October 1st, excluding winter vacation in July) and was followed by the posttest assessment, in which the same procedure used for the pretest was repeated (except that the CMMS and Demographic information questionnaire were not administered, so five individual sessions of approximately 20 min were performed).
After blocking with blocking agent (Dako REAL Peroxidase-Blocking Solution) for 5 min at room temperature, incubations with the primary antibody against pimonidazole (FITC-MAb1, 1/100 dilution) for 30 min and the second antibody (HRP linked to rabbit anti-FITC, 1/100 dilution with Dako REAL Antibody Diluent) for 30 min were performed in order.
The following PCR conditions, an initial denaturation at 95°C for 5 min and 35 cycles at 95°C for 30 s, specific T° annealing for 30 s, 72°C for 40 s, and a final elongation to 72°C 7 min were performed.
45 cycles (95°C for 15 sec and 60°C for 1 min) were performed in an ABI sequence detector 7500 (Applied Biosystems).
Fifteen PCR cycles of 94°C for 7 s, 66°C for 30 s, and 72°C for 6 min were performed.
